Cargando…
Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B Leukemic Cells
BACKGROUND: Cucurbitacin-I (JSI-124) is potent inhibitor of JAK/STAT3 signaling pathway and has anti-tumor activity in a variety of cancer including B cell leukemia. However, other molecular targets of JSI-124 beyond the JAK/STAT3 pathway are not fully understood. METHODS: BJAB, I-83, NALM-6 and pri...
Autores principales: | Ishdorj, Ganchimeg, Johnston, James B, Gibson, Spencer B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146936/ https://www.ncbi.nlm.nih.gov/pubmed/21702955 http://dx.doi.org/10.1186/1471-2407-11-268 |
Ejemplares similares
-
JSI-124 Induces Cell Cycle Arrest and Regulates the Apoptosis in Glioblastoma Cells
por: Tsai, Tai-Hsin, et al.
Publicado: (2023) -
JSI-124 Suppresses Invasion and Angiogenesis of Glioblastoma Cells In Vitro
por: Yuan, Guang, et al.
Publicado: (2015) -
The effects of cucurbitacin E on GADD45β‐trigger G2/M arrest and JNK‐independent pathway in brain cancer cells
por: Cheng, An‐Chin, et al.
Publicado: (2019) -
Dasatinib synergizes with JSI-124 to inhibit growth and migration and induce apoptosis of malignant human glioma cells
por: Premkumar, Daniel R., et al.
Publicado: (2010) -
Nerve Injury-Induced c-Jun Activation in Schwann Cells Is JNK Independent
por: Lindwall Blom, Charlotta, et al.
Publicado: (2014)